KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Dividends payables (2016 - 2025)

Historic Dividends payables for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.

  • Abbott Laboratories' Dividends payables rose 774.06% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 774.06%. This contributed to the annual value of $1.0 billion for FY2024, which is 722.51% up from last year.
  • As of Q3 2025, Abbott Laboratories' Dividends payables stood at $1.0 billion, which was up 774.06% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Dividends payables ranged from a high of $1.0 billion in Q1 2025 and a low of $797.0 million during Q3 2021
  • In the last 5 years, Abbott Laboratories' Dividends payables had a median value of $887.0 million in 2022 and averaged $904.6 million.
  • Its Dividends payables has fluctuated over the past 5 years, first surged by 2574.57% in 2021, then soared by 287.14% in 2022.
  • Abbott Laboratories' Dividends payables (Quarter) stood at $831.0 million in 2021, then rose by 6.74% to $887.0 million in 2022, then rose by 7.67% to $955.0 million in 2023, then rose by 7.23% to $1.0 billion in 2024, then grew by 0.59% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.0 billion during Q1 2025.